Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhibition of FLT3 tyrosine kinase: an evolving therapeutic strategy in acute myeloid leukemia

Inhibition of FLT3 tyrosine kinase: an evolving therapeutic strategy in acute myeloid leukemia. 2nd International Symposium on Signal Transduction Modulators in Cancer Therapy. 2003; 22.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.